Jes Hathaway is the editor in chief of National Fisherman magazine and NationalFisherman.com.
Thursday, 06 December 2012
It sounds like the spawning grounds for Frankenfish are expected to dry up in January.
Massachusetts-based Aquabounty is crying foul over Food and Drug Administration delays in the company's approval process for genetically modified salmon.
Welcome to the world of fishery management, Aquabounty!
OK, OK, so they're dealing with the FDA. But it's the same deal, isn't it?
You want to make a change in your business, but it has to go through the long process of government approval. In the meantime, you may have to shut down completely.
Fishermen on every coast have faced the same fate. Just because you've poured money into manipulating nature rather than harvesting her bounty doesn't make you a special case. Well, it does, but probably not in the way you'd hoped.
In the meantime, all of this delay has some scientists worried that an Aquabounty failure would discourage investments in animal biotechnology.
Again, this is par for the course when it comes to introducing potentially hazardous food sources to the mainstream. Also, I'm not seeing the downside.
We've recently seen reversals on Canadian recommendations for salmon net pens. That technology was once heralded as a great scientific advancement. But it turned out to be infectious. Again, not in the way it was intended.
Maybe in this case the blessing of slow-grinding government wheels is that we get a window for hindsight before making a potentially disastrous first step.
National Fisherman Live: 11/06/14
In this episode:
NOAA report touts 2013 landings, value increases
Panama fines GM salmon company Aquabounty
Gulf council passes Reef Fish Amendment 40
Maine elver quota cut by 2,000 pounds
Offshore mussel farm would be East Coast’s first